EGFR and non-small cell lung carcinoma: Some scholars have carried out a randomized controlled trial (Yang et al., 2018) to observe the clinical efficacy of Yiqi Yangyin Sanjie Decoction combined with EGFR-TKIs in the treatment of advanced NSCLC with secondary resistance to EGFR-TKIs.